Literature DB >> 23429703

Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1.

Issam Ben-Sahra1, Jessica J Howell, John M Asara, Brendan D Manning.   

Abstract

Cellular growth signals stimulate anabolic processes. The mechanistic target of rapamycin complex 1 (mTORC1) is a protein kinase that senses growth signals to regulate anabolic growth and proliferation. Activation of mTORC1 led to the acute stimulation of metabolic flux through the de novo pyrimidine synthesis pathway. mTORC1 signaling posttranslationally regulated this metabolic pathway via its downstream target ribosomal protein S6 kinase 1 (S6K1), which directly phosphorylates S1859 on CAD (carbamoyl-phosphate synthetase 2, aspartate transcarbamoylase, dihydroorotase), the enzyme that catalyzes the first three steps of de novo pyrimidine synthesis. Growth signaling through mTORC1 thus stimulates the production of new nucleotides to accommodate an increase in RNA and DNA synthesis needed for ribosome biogenesis and anabolic growth.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23429703      PMCID: PMC3753690          DOI: 10.1126/science.1228792

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  23 in total

Review 1.  Assays of glucose entry, glucose transporter amount, and translocation.

Authors:  J F Tanti; M Cormont; T Grémeaux; Y Le Marchand-Brustel
Journal:  Methods Mol Biol       Date:  2001

2.  Regulation of carbamoyl phosphate synthetase by MAP kinase.

Authors:  L M Graves; H I Guy; P Kozlowski; M Huang; E Lazarowski; R M Pope; M A Collins; E N Dahlstrand; H S Earp; D R Evans
Journal:  Nature       Date:  2000-01-20       Impact factor: 49.962

Review 3.  mTOR signaling in growth control and disease.

Authors:  Mathieu Laplante; David M Sabatini
Journal:  Cell       Date:  2012-04-13       Impact factor: 41.582

4.  Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis.

Authors:  Jason W Locasale; Alexandra R Grassian; Tamar Melman; Costas A Lyssiotis; Katherine R Mattaini; Adam J Bass; Gregory Heffron; Christian M Metallo; Taru Muranen; Hadar Sharfi; Atsuo T Sasaki; Dimitrios Anastasiou; Edouard Mullarky; Natalie I Vokes; Mika Sasaki; Rameen Beroukhim; Gregory Stephanopoulos; Azra H Ligon; Matthew Meyerson; Andrea L Richardson; Lynda Chin; Gerhard Wagner; John M Asara; Joan S Brugge; Lewis C Cantley; Matthew G Vander Heiden
Journal:  Nat Genet       Date:  2011-07-31       Impact factor: 38.330

5.  Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling.

Authors:  Yonghao Yu; Sang-Oh Yoon; George Poulogiannis; Qian Yang; Xiaoju Max Ma; Judit Villén; Neil Kubica; Gregory R Hoffman; Lewis C Cantley; Steven P Gygi; John Blenis
Journal:  Science       Date:  2011-06-10       Impact factor: 47.728

6.  A multienzyme complex of carbamoyl-phosphate synthase (glutamine): aspartate carbamoyltransferase: dihydoorotase (rat ascites hepatoma cells and rat liver).

Authors:  M Mori; M Tatibana
Journal:  Methods Enzymol       Date:  1978       Impact factor: 1.600

7.  Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism.

Authors:  Haoqiang Ying; Alec C Kimmelman; Costas A Lyssiotis; Sujun Hua; Gerald C Chu; Eliot Fletcher-Sananikone; Jason W Locasale; Jaekyoung Son; Hailei Zhang; Jonathan L Coloff; Haiyan Yan; Wei Wang; Shujuan Chen; Andrea Viale; Hongwu Zheng; Ji-hye Paik; Carol Lim; Alexander R Guimaraes; Eric S Martin; Jeffery Chang; Aram F Hezel; Samuel R Perry; Jian Hu; Boyi Gan; Yonghong Xiao; John M Asara; Ralph Weissleder; Y Alan Wang; Lynda Chin; Lewis C Cantley; Ronald A DePinho
Journal:  Cell       Date:  2012-04-27       Impact factor: 41.582

8.  A positive/negative ion-switching, targeted mass spectrometry-based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue.

Authors:  Min Yuan; Susanne B Breitkopf; Xuemei Yang; John M Asara
Journal:  Nat Protoc       Date:  2012-04-12       Impact factor: 13.491

9.  PTEN induces cell cycle arrest by decreasing the level and nuclear localization of cyclin D1.

Authors:  Aurelian Radu; Valerie Neubauer; Tsuyoshi Akagi; Hidesaburo Hanafusa; Maria-Magdalena Georgescu
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

10.  Roles of the mammalian target of rapamycin, mTOR, in controlling ribosome biogenesis and protein synthesis.

Authors:  Valentina Iadevaia; Yilin Huo; Ze Zhang; Leonard J Foster; Christopher G Proud
Journal:  Biochem Soc Trans       Date:  2012-02       Impact factor: 5.407

View more
  308 in total

Review 1.  mTOR in health and in sickness.

Authors:  Dritan Liko; Michael N Hall
Journal:  J Mol Med (Berl)       Date:  2015-09-22       Impact factor: 4.599

2.  Rethinking glutamine addiction.

Authors:  Abigail S Krall; Heather R Christofk
Journal:  Nat Cell Biol       Date:  2015-12       Impact factor: 28.824

3.  Inhibition of nucleotide synthesis promotes replicative senescence of human mammary epithelial cells.

Authors:  Alireza Delfarah; Sydney Parrish; Jason A Junge; Jesse Yang; Frances Seo; Si Li; John Mac; Pin Wang; Scott E Fraser; Nicholas A Graham
Journal:  J Biol Chem       Date:  2019-05-28       Impact factor: 5.157

Review 4.  MenTORing Immunity: mTOR Signaling in the Development and Function of Tissue-Resident Immune Cells.

Authors:  Russell G Jones; Edward J Pearce
Journal:  Immunity       Date:  2017-05-16       Impact factor: 31.745

5.  Low-dose radiation exposure induces a HIF-1-mediated adaptive and protective metabolic response.

Authors:  R Lall; S Ganapathy; M Yang; S Xiao; T Xu; H Su; M Shadfan; J M Asara; C S Ha; I Ben-Sahra; B D Manning; J B Little; Z-M Yuan
Journal:  Cell Death Differ       Date:  2014-02-28       Impact factor: 15.828

Review 6.  The molecular rationale for therapeutic targeting of glutamine metabolism in pulmonary hypertension.

Authors:  Thomas Bertero; Dror Perk; Stephen Y Chan
Journal:  Expert Opin Ther Targets       Date:  2019-05-11       Impact factor: 6.902

7.  The adaptor protein p66Shc inhibits mTOR-dependent anabolic metabolism.

Authors:  Mohamed A Soliman; Anas M Abdel Rahman; Dudley W Lamming; Dudley A Lamming; Kivanç Birsoy; Judy Pawling; Maria E Frigolet; Huogen Lu; I George Fantus; Adrian Pasculescu; Yong Zheng; David M Sabatini; James W Dennis; Tony Pawson
Journal:  Sci Signal       Date:  2014-02-18       Impact factor: 8.192

8.  Chromosome 3p loss of heterozygosity is associated with a unique metabolic network in clear cell renal carcinoma.

Authors:  Francesco Gatto; Intawat Nookaew; Jens Nielsen
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-18       Impact factor: 11.205

9.  A Legume TOR Protein Kinase Regulates Rhizobium Symbiosis and Is Essential for Infection and Nodule Development.

Authors:  Kalpana Nanjareddy; Lourdes Blanco; Manoj-Kumar Arthikala; Xóchitl Alvarado-Affantranger; Carmen Quinto; Federico Sánchez; Miguel Lara
Journal:  Plant Physiol       Date:  2016-10-03       Impact factor: 8.340

10.  Emerging role of mTOR in the response to cancer therapeutics.

Authors:  Erika Ilagan; Brendan D Manning
Journal:  Trends Cancer       Date:  2016-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.